Author (Corporate) | European Medicines Agency |
---|---|
Series Title | Press Release |
Series Details | EMA/CHMP/588294/2010 (23.9.10) |
Publication Date | 23/09/2010 |
Content Type | News |
Having reviewed all available data on the suspected link between narcolepsy and Pandemrix, The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) concluded, in September 2010, that the available evidence was insufficient to determine whether there was any link between Pandemrix and reports of narcolepsy, and that further studies were necessary to fully understand this issue. |
|
Source Link | Link to Main Source http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/09/news_detail_001120.jsp&mid=WC0b01ac058004d5c1&murl=menus/news_and_events/news_and_events.jsp |
Related Links |
|
Subject Categories | Health |
Countries / Regions | Europe |